For the policies on research and publication ethics not stated in the Instructions, Guidelines on Good Publication (http://publicationethics.org/) or Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/) can be applied.
|JOURNAL CONTENT||JOURNAL PRACTICES||ORGANISATION||BUSINESS PRACTICES|
The official journal title is Journal of Rheumatic Diseases. Abbreviated title is JRD.
i. The URL address of official journal web site is http://www.jrd.or.kr/
ii. 'Aims & Scope' statement: Journal of Rheumatic Diseases (JRD) is a peer reviewed journal that publishes original articles, reviews, and editorials on all aspects of rheumatic diseases, including clinical investigations and basic research. Both human and experimental animal studies are welcome, as are new findings on the epidemiology, pathogenesis, diagnosis, and treatment of rheumatic diseases. Case reports will be published only in exceptional circumstances, when they illustrate a rare occurrence of clinical importance.
iii. Readership: The JRD target reader includes academicians, scientists, practitioners, and students from all disciplines of rheumatology.
iv. Authorship criteria: Authorship credit should be based on: 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreeing to be accountable for all aspects of the work in ensuring that the questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet these 4 conditions. If the number of authors is greater than 6, there should be a list of each author's role in the submitted paper. If any persons who do not meet the above four criteria, they may be placed as contributors in the Acknowledgments section. Description of co-first authors or co-corresponding authors is also accepted if the corresponding author believes that such roles existed in contributing to the manuscript.
v. Duplicate submission and redundant publication All submitted manuscripts should be original and should not be in consideration by other scientific journals for publication. Any part of the accepted manuscript should not be duplicated in any other scientific journal without the permission of the Editorial Board, although the figures and tables can be used freely if the original source is verified according to Creative Commons license. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from other journal that is not open access.
vi. pISSN: 2093-940X eISSN: 2233-4718
Journal of Rheumatic Diseases is published quarterly a year (First day of January, April, July, and October).
Copyright policy: It is not allowed for another journal to publish a manuscript that is the same as or similar to that submitted to the JRD. In addition, the KCR possesses the copyright of a manuscript whose publishing has been decided and is authorized to publish, distribute or print the manuscript in the JRD or other media.
Licensing information: This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/).
Every manuscript submitted should be double-blind peer-reviewed by two or more relevant experts (3 most relevant investigators available for review of the original article and case report), as regards the appropriateness of publishing. Its publishing should be decided on the basis of the deliberation and its author may be advised to revise or complement its content. Advised to revise its content, the author should revise the manuscript and submit the revised manuscript along with his/her answer on the processing of the items pointed out by judges in a file form.
The revised manuscript should be resubmitted via the web system. Failure to resubmit the revised manuscript within 2 months without any notice from the corresponding author is regarded as a withdrawal. All manuscripts from editors, employees, or members of the editorial board are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts even if they are commissioned ones.
This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
i. Information about the ownership: This journal is owned by the publisher, the Korean College of Rheumatology http://www.rheum.or.kr/.
ii. Management team of a journal
Journal management team
- Journal Manager: Hyeon-Jeong Kim, Korean College of Rheumatology, Korea
Jieun Ryu, Korean College of Rheumatology, Korea
- Manuscript Editor: Seokhyun Kang, MEDrang Inc., Korea
- Layout Editor: Sora Kim, MEDrang Inc., Korea
- Website and JATS XML File Producer: Seon Woo Lim, INFOrang Inc., Korea
The advisory body is the journal's editorial board. The full names and affiliations of the journal’s editors are displayed on the About (Editorial Board) tab of the journal website.
Editorial team is available from Editorial Board page at the front part of the journal.
Editorial Staff: Hyeon-Jeong Kim
Raemian Yongsan A Building 1917, 95 Hangang-daero, Yongsan-gu, Seoul, 04378, Korea
Administrative Manager: Jae-Eun Yu
32, Mugyo-ro, Jung-gu, Seoul, 04521, Korea
There is no publication fee to submit or publish content in JRD.
Budget of the journal publishing was supported by the Korean College of Rheumatology, advertisement, and the Korean ederation of Science Technological Societies granted by Korean Government.
i. All advertisements are subject to approval of the Journal of Rheumatic Diseases and Korean College of heumatology, which reserves the right to reject or cancel any advertisement at any time.
ii. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an ad.
iii. For ad contact our office.
There are no marketing activities since it is non-profit scholarly journal published by the non-profit organization publisher, the Korean College of Rheumatology.
Ji-Hyoun Kang, M.D., Ph.D., Sung-Eun Choi, M.D., Dong-Jin Park, M.D., Ph.D., Shin-Seok Lee, M.D., Ph.D.J Rheum Dis 2022;29: 4-13
Chong Hyuk Chung, M.D.*, Gyuho Jang, M.D.*, Chang-Hoon Lee, M.D., Ph.D.J Rheum Dis 2021;28: 31-37
Hyoungyoung Kim, M.D., M.S., Yoon-Kyoung Sung, M.D., Ph.D., MPHJ Rheum Dis 2021;28: 60-67
Robert D Inman, M.D., FRCPC, FACP, FRCP EdinJ Rheum Dis 2021;28: 55-59